Validation of monoplex assays detecting antibodies against Corynebacterium diphtheriae and Clostridium tetani toxins, rubella virus and parvovirus B19 for incorporation into Multiplex Serology
- PMID: 30703462
- DOI: 10.1016/j.ymeth.2019.01.013
Validation of monoplex assays detecting antibodies against Corynebacterium diphtheriae and Clostridium tetani toxins, rubella virus and parvovirus B19 for incorporation into Multiplex Serology
Abstract
Serological assays detecting antibodies in serum or plasma samples are useful and versatile instruments to investigate an individual's infection and vaccination history, e.g. for clinical diagnosis, personal risk evaluation, and seroepidemiological studies. Multiplex Serology is a suspension bead array-based high-throughput methodology for simultaneous measurement of antibodies against multiple pathogens in a single reaction vessel, thus economizing sample volume, measurement time, and costs. We developed and validated bead-based pathogen-specific Monoplex Serology assays, i.e. assays including only antigens for the respective pathogen, to detect antibodies against Corynebacterium diphtheriae and Clostridium tetani toxins, rubella virus and parvovirus B19. The developed assays expand the portfolio of existing pathogen-specific bead-based serology assays and can be efficiently incorporated into larger Multiplex Serology panels. The newly developed Monoplex Serology assays consist of only one antigen per infectious agent, expressed as Glutathione S-transferase-fusion proteins in E. coli. Specificity, sensitivity and Cohen's kappa statistics in comparison with routine clinical diagnostic assays were calculated for serum dilutions 1:100 and 1:1000. All pathogen-specific assays were successfully validated at both serum dilutions with the exception of rubella Monoplex Serology which showed impaired sensitivity (57.6%) at dilution 1:1000. Specificities of successfully validated Monoplex Serology assays ranged from 85.6% to 100.0% (median: 91.7%), and sensitivities from 81.3% to 95.8% (median: 90.9%); agreement with the reference assays ranged from substantial to almost perfect (kappa: 0.66-0.86, median: 0.78). Statistical performance and slim assay design enable efficient incorporation of the developed assays into Multiplex Serology.
Keywords: High-throughput assay; Multiplex; Parvovirus B19; Serology; Vaccine-preventable diseases.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Development and validation of magnetic bead pentaplex immunoassay for simultaneous quantification of murine serum IgG antibodies to acellular pertussis, diphtheria and tetanus antigens used in combination vaccines.Methods. 2019 Apr 1;158:33-43. doi: 10.1016/j.ymeth.2019.01.015. Epub 2019 Jan 25. Methods. 2019. PMID: 30690077
-
Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondii.PLoS One. 2019 Jan 7;14(1):e0210407. doi: 10.1371/journal.pone.0210407. eCollection 2019. PLoS One. 2019. PMID: 30615688 Free PMC article.
-
Microsphere-Based IgM and IgG Avidity Assays for Human Parvovirus B19, Human Cytomegalovirus, and Toxoplasma gondii.mSphere. 2020 Mar 18;5(2):e00905-19. doi: 10.1128/mSphere.00905-19. mSphere. 2020. PMID: 32188754 Free PMC article.
-
Vaccination against diphtheria and tetanus. Assays, antigens, adjuvants and application.APMIS Suppl. 1998;81:1-40. APMIS Suppl. 1998. PMID: 9810281 Review. No abstract available.
-
Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.Clin Infect Dis. 1996 Dec;23(6):1255-60. doi: 10.1093/clinids/23.6.1255. Clin Infect Dis. 1996. PMID: 8953068 Review.
Cited by
-
Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis.Eur J Neurol. 2024 Oct;31(10):e16387. doi: 10.1111/ene.16387. Epub 2024 Jul 18. Eur J Neurol. 2024. PMID: 39023088 Free PMC article.
-
Quantitative analysis of pertussis, tetanus, and diphtheria antibodies in sera and breast milk from Tdap vaccinated women using a qualified multiplex assay.mSphere. 2024 Apr 23;9(4):e0052723. doi: 10.1128/msphere.00527-23. Epub 2024 Mar 18. mSphere. 2024. PMID: 38497618 Free PMC article.
-
Associations of genetic and infectious risk factors with coronary heart disease.Elife. 2023 Feb 14;12:e79742. doi: 10.7554/eLife.79742. Elife. 2023. PMID: 36785929 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
